Accession Number: | 0001127602-21-012654 |
Date: | 2021-04-01 |
Issuer: | UNITED THERAPEUTICS CORP (UTHR) |
Original Submission Date: |
OLIAN JUDY D.
C/O UNITED THERAPEUTICS CORP
1040 SPRING STREET
SILVER SPRING, MD 20910
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-04-01 | M | 4,207 | a | $76.36 | 9,997 | direct | ||
COMMON STOCK | 2021-04-01 | S | 4,207 | d | $184.96 | 5,790 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS | 76.36 | 2021-04-01 | deemed execution date | M | 4,207 (d) | 2020-06-26 | 2029-06-26 | common stock 4,207 | $76.36 | 0 | direct |
ID | footnote |
---|---|
f1 | this exercise of stock options and subsequent sale of shares was pursuant to a rule 10b5-1 trading plan entered into by the reporting person. |